韩彦峰 邹淑伟 王宝华
[摘要] 目的 探讨双模(超声造影结合彩色多普勒超声)在评估乳腺癌新辅助化疗(NAC)中的应用价值。 方法 选取2016年3月~2017年3月台州市中西医结合医院收治的65例乳腺癌患者作为观察对象。所有患者术前均接受NAC,于NAC前后进行超声造影以及彩色多普勒超声(CDFI)检查,观察超声造影、CDFI声像图特点及联合应用在评估乳腺癌NAC疗效中的应用价值。 结果 根据NAC病理系统分级标准将经NAC治疗的65例乳腺癌患者可分为化疗有效54例,无效11例,单纯CDFI对疗效评估敏感性为79.25%,特异性为33.33%,双模联合CDFI超声对疗效评估敏感性为96.23%,特异性为75.00%,双模联合超声检查对疗效评估的敏感性明显高于单纯CDFI,一致性分析结果显示Kappa值为0.664,双模态联合超声评估NAC疗效的敏感性高于单纯CDFI,并且Kappa值明显高于单纯CDFI评估结果(Kappa值为0.512);超声造影检查中乳腺癌患者NAC前后患者达峰時间(TTP)、增强时间(MTT)比较,差异无统计学意义(t=1.052、1.179,均P > 0.05),但化疗后患者峰值强度(PI)、曲线下面积明显低于NAC化疗前,差异有统计学意义(t=4.513、125.631,均P < 0.05);病理评估NAC有效缓和峰值强度变化率明显高于无效患者,差异有统计学意义(t=5.916,P < 0.05),而构建的ROC曲线显示以灵敏度、特异度之和最大对应的峰值强度变化率作为截断值,在分辨NAC是否有效时最为准确。 结论 双模态超声造影结合CDFI检查能够准确评估乳腺癌NAC治疗效果,较单纯CDFI评估结果更为可靠、准确,具有临床应用及推广价值。
[关键词] 超声造影;彩色多普勒超声;乳腺癌;新辅助化疗;疗效评估
[中图分类号] R737.9、R445.1 [文献标识码] A [文章编号] 1673-7210(2018)05(a)-0105-04
[Abstract] Objective To discuss the value in the neoadjuvant chemotherapy for breast cancer with contrast-enhanced ultrasonography and color Doppler ultrasound. Methods From March 2016 to March 2017, 65 cases of breast cancer patients in Chinese and Western Medicine Hospital of Taizhou were selected as the observe object, all patients underwent neoadjuvant chemotherapy (NAC), ultrasound imaging and color Doppler ultrasound (CDFI) examination were used before and after NAC. The value of contrast-enhanced ultrasonography, CDFI ultrasonography and combined application in assessing the efficacy of NAC in breast cancer were observed. Results According to the Miller and Payne pathology classification criteria, all the patients could be divided into chemotherapy (54 cases) and ineffective (11 cases) after NAC treatment. The sensitivity of CDFI was 79.25%, the specificity was 33.33%, the sensitivity of the dual-mode and CDFI ultrasound was 96.23%, the specificity was 75.00%. The accuracy of the dual-mode and ultrasound examination was significantly higher than CDFI, the results of the coherence analysis showed that the Kappa value was 0.664, the patients underwent CEUS before and after NAC. There was no significant difference in time (TTP) and enhancement time (MTT), the differences was not statistically significant (t=1.052, 1.179, all P > 0.05), the peak intensity (PI) and area under the curve were significantly lower after chemotherapy than before NAC, the differences were statistically significant (t = 4.513, 125.631, all P < 0.05), pathological assessment of NAC effective relief of peak intensity changes was significantly higher than ineffective patients, the difference was statistically significant (t = 5.916, P < 0.05). The ROC curve showed that is the most accurate when resolving NAC validity by the peak intensity change rate corresponding to the sum of sensitivity and specificity was used as the cutoff value. Conclusion Dual-mode contrast-enhanced ultrasonography combined with CDFI examination can accurately assess the effect of breast cancer NAC treatment, relative to the CDFI evaluation, the results are more reliable, accurate, it can be widely used in the clinical.
[Key words] Contrast-enhanced ultrasonography; Color Doppler ultrasonography; Breast cancer; Neoadjuvant chemotherapy; Efficacy evaluation
新辅助化疗(neoadjuvant chemotherapy,NAC)目前已成为乳腺癌术前常用的治疗方案,其目的为通过NAC控制、减小肿瘤的体积,消灭肿瘤周围病灶,控制肿瘤对周围组织的浸润,使患者尽可能的满足外科手术治疗要求,提升乳腺癌临床治疗效果,改善患者近远期生存率及生活质量[1-2]。因此对于乳腺癌NAC疗效的准确评估具有重要的临……